Spectropathologic endorsement of ocular carotenoids for early detection of diabetic retinopathy

Spectrochim Acta A Mol Biomol Spectrosc. 2022 Mar 5:268:120676. doi: 10.1016/j.saa.2021.120676. Epub 2021 Nov 30.

Abstract

Diabetic retinopathy (DR) is a common health concern. Unfortunately, the metabolic pathway causing DR is yet to be understood. The carotenoid level in the human body is known to protect the health of the eyes. In this work, resonance Raman spectroscopy and multivariate analysis of the spectral data of human serum are reported as next-generation spectropathologic tools to detect retinal degeneration efficiently. The proposed technique shows promise by endorsing ocular carotenoids as a critical biomarker for such pathosis. Furthermore, the multivariate analysis of the spectral data distinguishes between two different stages of the disease. The machine learning algorithm is used to estimate a significant accuracy of 94% of the proposed model for the classification. As the carotenoid level can be controlled by dietary intake, we believe that the reported results also indicate a therapeutic role of the same in DR.

Keywords: Diabetes mellitus; Diabetic retinopathy; Multivariate analysis; Raman spectroscopy.

MeSH terms

  • Algorithms
  • Antioxidants
  • Carotenoids
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / diagnosis
  • Humans
  • Machine Learning

Substances

  • Antioxidants
  • Carotenoids